Skip to content
TrialScanner

NCT02903771

Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.

Phase 1CompletedKZIALead

Registry record

Lead sponsor
Kazia Therapeutics Limited
Conditions
Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
Primary completion
Mar 24, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02903771 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02903771: Phase I Study of Cantrixil... | TrialScanner